Chase Investment Counsel Corp Amgen Inc Transaction History
Chase Investment Counsel Corp
- $262 Million
- Q1 2024
A detailed history of Chase Investment Counsel Corp transactions in Amgen Inc stock. As of the latest transaction made, Chase Investment Counsel Corp holds 1,428 shares of AMGN stock, worth $443,936. This represents 0.16% of its overall portfolio holdings.
Number of Shares
1,428
Previous 1,341
6.49%
Holding current value
$443,936
Previous $386,000
5.18%
% of portfolio
0.16%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding AMGN
# of Institutions
2,933Shares Held
401MCall Options Held
6.59MPut Options Held
6.6M-
Vanguard Group Inc Valley Forge, PA52.1MShares$16.2 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY48MShares$14.9 Billion0.32% of portfolio
-
State Street Corp Boston, MA29.1MShares$9.06 Billion0.38% of portfolio
-
Primecap Management CO Pasadena, CA14.6MShares$4.54 Billion3.15% of portfolio
-
Morgan Stanley New York, NY14MShares$4.34 Billion0.32% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $166B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...